以生物信息学为基础,探索铜代谢在慢性淋巴结膜炎中所起的作用
Lingjun Sun1, Xiaoying Deng2, Beibei Yang3
1Department of Nephrology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Medicine
|November 8, 2025
概括
铜的新陈代谢,特别是基因阿基尼酶 (ACO1) 和超氧化解突变酶 (SOD2),在慢性淋巴结膜炎中起作用. 这些基因影响免疫细胞活动和炎症,可能导致疾病的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性淋巴结膜炎是一种常见的病.
- 铜代谢对人类健康至关重要,并与各种疾病有关.
- 铜代谢在慢性淋巴结膜炎中的特定作用需要进一步研究.
研究的目的:
- 调查铜代谢相关基因 (CMRGs) 在慢性淋巴结膜炎的发展和进展中的参与.
- 为了确定关键的基因和与这种情况中的铜代谢相关的途径.
主要方法:
- 对差异表达基因的公开微阵列数据集 (GSE66494,GSE32591,GSE116626) 的分析.
- 使用STRING和Cytoscape构建一个蛋白质与蛋白质相互作用 (PPI) 网络.
- 在患者组织中使用RT-qPCR验证关键基因 (ACO1,SOD2).
- 使用CIBERSORT分析评估免疫细胞透的情况.
主要成果:
- 确定了25个不同表达的CMRG,其中11个是上调和14个是下调.
- 在狼性炎中,阿基尼酶 (ACO1) 的表达较低,而在IgA脏病和糖尿病脏病中,超氧化失调酶 (SOD2) 的表达较高.
- 免疫细胞的透 (T 细胞,B 细胞,巨细胞) 与慢性淋巴结膜炎显著相关,这些细胞参与铜代谢.
结论:
- 与铜代谢相关的基因 ACO1 和 SOD2 涉及慢性淋巴结膜炎.
- 这些基因通过调节免疫细胞功能来调节炎症反应和免疫微环境,可能会影响疾病的进展.
相关概念视频
01:20Renal Corpuscle
6.9K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
6.9K
01:25Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
01:24Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
01:28Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208